Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 8,541 | 8,056 | 7,679 | 7,190 | 7,338 |
| Cost of Goods | 714 | 735 | 756 | 887 | 455 |
| Gross Profit | 7,827 | 7,321 | 6,923 | 6,303 | 6,883 |
| Operating Expenses | 29,621 | 40,292 | 43,500 | 42,627 | 38,984 |
| Operating Income | -21,080 | -32,236 | -35,821 | -35,437 | -31,646 |
| Interest Expense | 3,843 | 4,617 | 4,346 | 4,298 | 4,242 |
| Other Income | 698 | 1,025 | 1,498 | -2,034 | 2,916 |
| Pre-tax Income | -24,225 | -35,828 | -38,669 | -41,769 | -32,972 |
| Net Income Continuous | -24,225 | -35,828 | -38,669 | -41,769 | -32,972 |
| Net Income | $-24,225 | $-35,828 | $-38,669 | $-41,769 | $-32,972 |
| EPS Basic Total Ops | -0.42 | -0.63 | -0.68 | -0.74 | -0.61 |
| EPS Basic Continuous Ops | -0.42 | -0.63 | -0.68 | -0.74 | -0.61 |
| EPS Diluted Total Ops | -0.42 | -0.63 | -0.68 | -0.74 | -0.61 |
| EPS Diluted Continuous Ops | -0.42 | -0.63 | -0.68 | -0.74 | -0.61 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.60 | -0.68 | -0.74 | -0.61 |
| EBITDA(a) | $-20,191 | $-31,863 | $-35,567 | $-35,063 | $-31,695 |